Back to BAKER BROS. ADVISORS LP

BAKER BROS. ADVISORS LP

Q3 2026 13F filing

Updated 6 days ago

80 disclosed positions worth $21B

Portfolio value
$21B
Total holdings
80
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-11-16

Full holdings

Every line item disclosed in Q3 2026

I

Incyte Corporation

Value
$3.7B
Shares
30.76M
% Port
17.74%
B

BeOne Medicines Ltd.

Value
$3.2B
Shares
8.83M
% Port
15.36%
R

Revolution Medicines, Inc.

Value
$2.2B
Shares
10.64M
% Port
10.38%
K
4.KOD

Kodiak Sciences Inc.

Value
$2.1B
Shares
21.86M
% Port
9.85%
M

Madrigal Pharmaceuticals, Inc.

Value
$1.1B
Shares
2.14M
% Port
5.13%
I

Insmed Incorporated

Value
$1B
Shares
8.80M
% Port
4.77%
K

Kymera Therapeutics, Inc.

Value
$967.8M
Shares
8.66M
% Port
4.60%
A

ACADIA Pharmaceuticals Inc.

Value
$864.7M
Shares
42.91M
% Port
4.11%
G

GRAIL, Inc.

Value
$564.5M
Shares
4.03M
% Port
2.68%
S
10.SMMT

Summit Therapeutics Inc.

Value
$554.4M
Shares
32.79M
% Port
2.63%
R
11.RYTM

Rhythm Pharmaceuticals, Inc.

Value
$533.6M
Shares
5.60M
% Port
2.54%
P
12.PRAX

Praxis Precision Medicines, Inc.

Value
$510.6M
Shares
1.75M
% Port
2.43%
A
13.ABCL

AbCellera Biologics Inc.

Value
$481.6M
Shares
33.01M
% Port
2.29%
A
14.ALKS

Alkermes plc

Value
$405.7M
Shares
10.01M
% Port
1.93%
C
15.CELC

Celcuity Inc.

Value
$383M
Shares
4.82M
% Port
1.82%
K
16.KNSA

Kiniksa Pharmaceuticals International, plc

Value
$211.5M
Shares
2.83M
% Port
1.00%
I
17.IDYA

IDEAYA Biosciences, Inc.

Value
$192.5M
Shares
5.01M
% Port
0.91%
E
18.EWTX

Edgewise Therapeutics, Inc.

Value
$150.3M
Shares
3.70M
% Port
0.71%
Q
19.QCOM

Replimune Group, Inc.

Value
$146.2M
Shares
11.05M
% Port
0.69%
R
20.ROIV

Roivant Sciences Ltd.

Value
$133.9M
Shares
3.66M
% Port
0.64%
A
21.ARWR

Arrowhead Pharmaceuticals, Inc.

Value
$111.9M
Shares
1.71M
% Port
0.53%
N
22.NRIX

Nurix Therapeutics, Inc.

Value
$110.5M
Shares
4.66M
% Port
0.52%
I
23.IMVT

Immunovant, Inc.

Value
$93.6M
Shares
2.77M
% Port
0.44%
C
24.CLDX

Celldex Therapeutics, Inc.

Value
$83.1M
Shares
2.56M
% Port
0.40%
D
25.DNLI

Denali Therapeutics Inc.

Value
$77.2M
Shares
3.73M
% Port
0.37%
D
26.DNTH

Dianthus Therapeutics, Inc.

Value
$75M
Shares
852.2K
% Port
0.36%
C
27.CELC

Celcuity Inc.

Value
$55.5M
Shares
30.75M
% Port
0.26%
R
28.RAPP

Rapport Therapeutics, Inc.

Value
$52M
Shares
1.55M
% Port
0.25%
M
29.MNST

Monte Rosa Therapeutics, Inc.

Value
$51.8M
Shares
4.35M
% Port
0.25%
R
30.RLAY

Relay Therapeutics, Inc.

Value
$51M
Shares
2.83M
% Port
0.24%
I
31.IONS

Ionis Pharmaceuticals, Inc.

Value
$45.7M
Shares
1.02M
% Port
0.22%
G
32.GPCR

Structure Therapeutics Inc.

Value
$44.8M
Shares
1.43M
% Port
0.21%
E
33.ELVN

Enliven Therapeutics, Inc.

Value
$41.5M
Shares
905.2K
% Port
0.20%
B
34.BCYC

Bicycle Therapeutics plc

Value
$40.1M
Shares
10.89M
% Port
0.19%
P
35.PRLD

Prelude Therapeutics Inc.

Value
$39.6M
Shares
10.12M
% Port
0.19%
M
36.MIRM

Mirum Pharmaceuticals, Inc.

Value
$38.1M
Shares
446.0K
% Port
0.18%
D
37.DSGN

Design Therapeutics, Inc.

Value
$37.6M
Shares
2.99M
% Port
0.18%
I
38.IMTX

Immatics N.V.

Value
$37.4M
Shares
4.26M
% Port
0.18%
S
39.STOK

Stoke Therapeutics, Inc.

Value
$34.2M
Shares
1.31M
% Port
0.16%
T
40.TRDA

Entrada Therapeutics, Inc.

Value
$32.2M
Shares
5.07M
% Port
0.15%
N
41.NGNE

Neurogene Inc.

Value
$27.6M
Shares
991.7K
% Port
0.13%
X
42.XNCR

Xencor, Inc.

Value
$27.5M
Shares
1.10M
% Port
0.13%
F
43.FTH

Faeth Therapeutics, Inc.

Value
$23.9M
Shares
803.4K
% Port
0.11%
A
44.ABSI

Absci Corporation

Value
$23M
Shares
2.13M
% Port
0.11%
I
45.IRON

Disc Medicine, Inc.

Value
$22.9M
Shares
349.7K
% Port
0.11%
R
46.RCUS

Arcus Biosciences, Inc.

Value
$21.8M
Shares
844.8K
% Port
0.10%
G
47.GENB

Generate Biomedicines, Inc.

Value
$21.4M
Shares
1.42M
% Port
0.10%
T
48.TSHA

Taysha Gene Therapies, Inc.

Value
$19.5M
Shares
4.00M
% Port
0.09%
A
49.AKTS

Aktis Oncology, Inc.

Value
$19.4M
Shares
996.4K
% Port
0.09%
J
50.JBIO

Jade Biosciences, Inc.

Value
$17.3M
Shares
1.23M
% Port
0.08%